ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new ...

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab has been approved in the US for the 1st-line treatment of adult patients with unresectable or ...

ENHERTU® Plus Pertuzumab Approved in the U.S. as First New Treatment in More Than a Decade ...

ENHERTU Plus Pertuzumab Approved in the U.S. for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer ...

Michael Burry Is Betting Big on Freddie Mac Stock Ahead of a Relisting. Should You?

Freddie Mac has surged more than 300% in a year and yet trades at a tiny fraction of its sales and cash flow, which helps ...
Asharq Al-Awsat

UN Appeals for $2.5 Billion to Confront Humanitarian Crisis in Yemen

The United Nations has warned of an unprecedented rise in humanitarian needs in Yemen during the coming year, saying the ...
Asharq Al-Awsat

Syria Welcomes Repeal of the ‘Caesar Act,’ Sees Step Toward Economic Recovery and ...

Syria’s Foreign Ministry on Thursday welcomed a vote by the US House of Representatives a day earlier in favor of repealing the Caesar Act, under which the United States imposed sanctions on former ...